Physician profile
Leon E Schwechter
NPI 1225078314
$13,177.89
in general payments reported to CMS, 2019-2025
67 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,449 · 2020: $1,489 · 2021: $2,231 · 2022: $1,542 · 2023: $1,822 · 2024: $2,474 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,468.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,157.52 | 2019-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $988.48 | 2020-2025 | Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $879.03 | 2019-2025 | |
| Pfizer INC. | $787.09 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $743.35 | 2024-2025 | Gemtesa, Myfembree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $686.85 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amarin Pharma, INC. | $680.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $493.90 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $419.31 | 2019-2025 | Spravato |
| Novo Nordisk INC | $363.97 | 2019-2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $333.24 | 2019-2024 | Breztri, Farxiga |
| Intuity Medical INC | $303.39 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Astellas Pharma US INC | $291.92 | 2019-2023 | Veozah, Myrbetriq |
| Abbott Laboratories | $282.41 | 2019-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $268.02 | 2019-2025 | Arexvy, Shingrix |
Show all 67 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Schwechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.